Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
Cytotherapy|April 15, 2018
Toward precision manufacturing of immunogene T-cell therapiesJun Xu, J Joseph Melenhorst, Joseph A Fraietta
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2011
Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cellsJ Joseph Melenhorst, Phillip Scheinberg, Ann Williams, et al.
Blood|November 11, 2008
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrowJ Joseph Melenhorst, Phillip Scheinberg, Pratip K Chattopadhyay, et al.
Cancers|February 13, 2025
Leveraging Vector-Based Gene Disruptions to Enhance CAR T-Cell EffectivenessBeatriz C Oliveira, Saaurav Bari, J Joseph Melenhorst
Stem Cell Research|December 24, 2014
Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cellsSawa Ito, A John Barrett, Amalia Dutra, et al.
Blood|August 17, 2010
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjectsJ Joseph Melenhorst, Ann M Leen, Catherine M Bollard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteinsHiroshi Fujiwara, J Joseph Melenhorst, Frank El Ouriaghli, et al.
Current Hematologic Malignancy Reports|January 15, 2021
High-Dimensional Immune Monitoring for Chimeric Antigen Receptor T Cell TherapiesSujata Sharma, David Quinn, J Joseph Melenhorst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Contribution of TCR-beta locus and HLA to the shape of the mature human Vbeta repertoireJ Joseph Melenhorst, Matthew D H Lay, David A Price, et al.
Pageof 22